Overview

Use of Corifolitropin Alfa in Oocyte Donors

Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if corifollitropin alfa (long-term gonadotropin administration) is effective in a controlled ovarian stimulation protocol in oocyte donors compared to daily gonadotropin administration (recombinant FSH or HP-hMG)
Phase:
Phase 4
Details
Lead Sponsor:
IVI Madrid
Collaborators:
Instituto Valenciano de Infertilidad, IVI Alicante
Instituto Valenciano de Infertilidad, IVI VALENCIA
Treatments:
Menotropins